1. Home
  2. ARBK vs RANI Comparison

ARBK vs RANI Comparison

Compare ARBK & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARBK
  • RANI
  • Stock Information
  • Founded
  • ARBK 2017
  • RANI 2012
  • Country
  • ARBK United Kingdom
  • RANI United States
  • Employees
  • ARBK N/A
  • RANI N/A
  • Industry
  • ARBK Finance: Consumer Services
  • RANI Medicinal Chemicals and Botanical Products
  • Sector
  • ARBK Finance
  • RANI Health Care
  • Exchange
  • ARBK Nasdaq
  • RANI Nasdaq
  • Market Cap
  • ARBK 20.1M
  • RANI 19.6M
  • IPO Year
  • ARBK 2021
  • RANI 2021
  • Fundamental
  • Price
  • ARBK $0.37
  • RANI $0.56
  • Analyst Decision
  • ARBK Hold
  • RANI Strong Buy
  • Analyst Count
  • ARBK 1
  • RANI 4
  • Target Price
  • ARBK N/A
  • RANI $7.75
  • AVG Volume (30 Days)
  • ARBK 252.8K
  • RANI 287.9K
  • Earning Date
  • ARBK 08-27-2025
  • RANI 08-05-2025
  • Dividend Yield
  • ARBK N/A
  • RANI N/A
  • EPS Growth
  • ARBK N/A
  • RANI N/A
  • EPS
  • ARBK N/A
  • RANI N/A
  • Revenue
  • ARBK $47,017,000.00
  • RANI $1,200,000.00
  • Revenue This Year
  • ARBK $183.90
  • RANI N/A
  • Revenue Next Year
  • ARBK $26.78
  • RANI N/A
  • P/E Ratio
  • ARBK N/A
  • RANI N/A
  • Revenue Growth
  • ARBK N/A
  • RANI N/A
  • 52 Week Low
  • ARBK $0.15
  • RANI $0.46
  • 52 Week High
  • ARBK $1.99
  • RANI $4.19
  • Technical
  • Relative Strength Index (RSI)
  • ARBK 46.08
  • RANI 35.97
  • Support Level
  • ARBK $0.35
  • RANI $0.51
  • Resistance Level
  • ARBK $0.39
  • RANI $0.56
  • Average True Range (ATR)
  • ARBK 0.03
  • RANI 0.03
  • MACD
  • ARBK -0.00
  • RANI 0.01
  • Stochastic Oscillator
  • ARBK 22.22
  • RANI 21.50

About ARBK Argo Blockchain plc

Argo Blockchain PLC is a data center business that provides a powerful and efficient platform for cryptocurrency mining operations. The company has operations in strategic locations in North America.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: